Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COPA study of cola to restore velpatasvir absorption during omeprazole use
NL-OMON46340Completed
- Sponsor
- Ziekenhuisapotheek
- Start
- Aug 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of velpatasvir and omeprazole in hepatitis C virus infection (6 arms), sponsored by Ziekenhuisapotheek. Primary endpoints: Velpatasvir AUC0-48h, Velpatasvir AUC0-inf and 5 more. Started Aug 2018; status: completed.
02
Drugs
velpatasviromeprazole
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NL-OMON46340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46340.